Akari Therapeutics PLC (AKTX)
1.19
-0.02
(-1.65%)
USD |
NASDAQ |
Apr 24, 16:00
1.17
-0.02
(-1.68%)
Pre-Market: 20:00
Akari Therapeutics Total Assets (Quarterly): 4.355M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.355M |
| June 30, 2023 | 8.013M |
| June 30, 2022 | 11.37M |
| March 31, 2022 | 19.45M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.65M |
| September 30, 2021 | 14.72M |
| June 30, 2021 | 4.830M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.355M
Minimum
Dec 2023
19.45M
Maximum
Mar 2022
10.63M
Average
11.37M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 182.99M |
| Adaptimmune Therapeutics PLC | 282.62M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| NuCana PLC | 35.43M |
| Genfit SA | 192.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.584M |
| Shareholders Equity (Quarterly) | -0.229M |